Home Health Care News March 7, 2025
Joyce Famakinwa

A prediction from an analyst, in January, that called the sale of Walgreens Boots Alliance Inc. (Nasdaq: WBA) to the PE firm Sycamore Partners “less likely” has been proven false, as news emerged that a deal has been inked.

On Thursday, Walgreens announced that it entered into an agreement to be acquired by Sycamore Partners. The total value of the transaction represents up to $23.7 billion, according to a company press statement.

This marks the latest chapter for Walgreens, which is among the major retail companies – such as Best Buy, Amazon and Walmart – that in recent years have made plays into the home-based care segment.

The company’s eponymous brand is one of the largest retail companies in the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
The Weapons of Getting Paid: Bringing Data, Technology, and Advocacy to the Battle
Will Trump Drug Tariffs Help Or Hurt The U.S.?
Johnson & Johnson Discontinues Pivotal Depression Drug Trial Due to Lack of Efficacy
First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
Medicare Coverage Of Medical Technologies In A New Era

Share This Article